The European Innovation Showcase is organized by the OIS community and is produced in collaboration with Emmetropes. The day will kick off with a fireside chat and special presentation followed by spotlight of exciting ophthalmic start-ups on July 20, 2021, 12:00 pm EDT / 6:00 pm CET. The day will close out with an industry panel discussion on what it takes to be successful in Europe.

GenSight Biologics is a Bronze sponsor at the OIS European Innovation Showcase.

Dr Magali Taiel, Chief Medical Officer, will present GenSight and its latest news about our most advanced product called LUMEVOQ® (GS010; lenadogene nolparvovec), a gene therapy targeting Leber Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease leading to blindness in young adults. The LUMEVOQ® MAA was filed in September 2020 and is currently in the review phase of its registration process in Europe. The EMA decision is expected in Q2 2022.

  • Day: July 20, 2021
  • Time: 12:45 – 2:10 PM EDT / 6:45 – 8:10 PM CET

You can register for free at the following link: